Form 8-K - Current report:
SEC Accession No. 0001213900-21-039847
Filing Date
2021-08-02
Accepted
2021-08-02 16:45:18
Documents
3
Period of Report
2021-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea145083-8k_180lifescien.htm 8-K 22845
2 COMMON STOCK PURCHASE WARRANT DATED JULY 31, 2021, TO PURCHASE 25,000 SHARES OF ea145083ex4-1_180lifescien.htm EX-4.1 91521
3 MUTUAL RELEASE AND SETTLEMENT AGREEMENT DATED JULY 31, 2021, ISSUED BY 180 LIFE ea145083ex10-1_180lifescien.htm EX-10.1 35688
  Complete submission text file 0001213900-21-039847.txt   151315
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211136636
SIC: 2834 Pharmaceutical Preparations